Generation of Novel Anti-CD19 Chimeric Antigen Receptor

Generation of Novel Anti-CD19 Chimeric Antigen Receptor

碩士 === 國立中正大學 === 生命科學系分子生物研究所 === 107 === In recent years, immunotherapy has become a promising novel cancer treatment. Particularly, chimeric antigen receptor T-cell immunotherapy has seen rapid development, because its ability to execute precise cytotoxic effect by recognizing the specific an...

Full description

Bibliographic Details
Main Authors:	CHANG , HUI-JU, 張惠茹
Other Authors:	LI , CHIN
Format:	Others
Language:	zh-TW
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/3w38up

Similar Items

Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia
by: Gina Ma, et al.
Published: (2018-01-01)

Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma
by: Li S, et al.
Published: (2019-07-01)

Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells
by: Daisuke Morita, et al.
Published: (2018-03-01)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
by: Hsiang-chi Tseng, et al.
Published: (2020-09-01)

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
by: Haiying Qin, et al.
Published: (2018-12-01)

Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
by: Veronika Mancikova, et al.
Published: (2020-06-01)

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
by: Maria Castella, et al.
Published: (2019-03-01)

T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
by: Keichiro Mihara, et al.
Published: (2017-06-01)

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
by: Runxia Gu, et al.
Published: (2020-09-01)

Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
by: Sudjit Luanpitpong, et al.
Published: (2021-01-01)

Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
by: Julio Delgado, et al.
Published: (2019-04-01)

Update on chimeric antigen receptor – T cells (CAR-T) CD19 therapy: the Sheba experience
by: Arnon Nagler
Published: (2020-10-01)

Immune escape mechanism of B-cell malignancies on Anti-CD19 Chimeric Antigen Receptor T-cell treatment and solution
by: Qian Jin
Published: (2021-01-01)

Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Recognition, Risk Factors, and Management
by: Ethan A. Burns, et al.
Published: (2021-03-01)

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
by: Xuan Zhou, et al.
Published: (2020-11-01)

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
by: Liqing Kang, et al.
Published: (2020-05-01)

Generation of hypoxia-sensing chimeric antigen receptor T cells
by: Paris Kosti, et al.
Published: (2021-09-01)

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
by: Zhitao Ying, et al.
Published: (2021-02-01)

The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis
by: Hui Zhou, et al.
Published: (2018-09-01)

CD8 Receptor-Targeted Lentiviral Vectors – an Approach for the in vivo Generation of Chimeric Antigen Receptor (CAR) T Cells
by: Pfeiffer, Anett
Published: (2018)

Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
by: Yitian Wang, et al.
Published: (2019-04-01)

Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR
by: Motoharu Hamada, et al.
Published: (2018-08-01)

Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?
by: Xun Lai, et al.
Published: (2020-01-01)

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
by: Yannick D. Muller, et al.
Published: (2021-03-01)

Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions
by: Will Garner, et al.
Published: (2021-02-01)

CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
by: Shabirul Haque, et al.
Published: (2021-03-01)

124 Optimizing the generation from umbilical cord blood of ‘off-the-shelf’ CD19-chimeric antigen receptor (CAR) expressing T cells
by: Mohammed Toufiq, et al.
Published: (2020-11-01)

Looking forward for chimeric antigen receptor therapy
by: Chen, Kevin Hui
Published: (2020)

Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
by: Xiaorui Li, et al.
Published: (2021-08-01)

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
by: Yongxian Hu, et al.
Published: (2016-08-01)

Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials.
by: Bipulendu Jena, et al.
Published: (2013-01-01)

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
by: Guoqing Wei, et al.
Published: (2017-04-01)

Chimeric antigen receptors that trigger phagocytosis
by: Meghan A Morrissey, et al.
Published: (2018-06-01)

Chimeric Antigen Receptor-T Cell Therapy
by: Jochen Buechner, et al.
Published: (2018-02-01)

The Chimeric Antigen Receptor Detection Toolkit
by: Yifei Hu, et al.
Published: (2020-08-01)

Engineering and Design of Chimeric Antigen Receptors
by: Sonia Guedan, et al.
Published: (2019-03-01)

Chimeric Antigen Receptors for T-Cell Malignancies
by: Lauren D. Scherer, et al.
Published: (2019-03-01)

4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
by: Qiang Dai, et al.
Published: (2020-11-01)

Novel BCMA-OR-CD38 tandem-dual chimeric antigen receptor T cells robustly control multiple myeloma
by: Yaru Feng, et al.
Published: (2021-01-01)

Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies
by: Qi Zhao
Published: (2019-10-01)